Russia to produce Sputnik V COVID-19 vaccine in India

Russia to produce Sputnik V COVID-19 vaccine in India

Mid-Day

Published

The Russian Direct Investment Fund (RDIF) and Hetero, one of India's generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of Sputnik V Covid-19 vaccine in India.

The parties intend to start the production of Sputnik V at the beginning of 2021.

"We are pleased to collaborate with...

Full Article